NBT
Microsources, Microspheres and Components for Radiotherapy
![]() |
Shareholders in Portfolio Company Industry Sector
Production Location Investment Started: 2009 |
Total Budget
0.90 bln rubles Co-investment by RUSNANO
0.71
bln rubles
|
bebig.ru |
Preparation and packaging of microsources for brachytherapy using isotope 125I. Production of nanostructured microspheres of amorphous material with isotope 90Y
Brachytherapy is a form of radiotherapy for malignant tumors in which the radiation source is placed within the affected organ. The optimal dose of radiation is delivered directly to the tumor without exposing adjacent tissues and organs. Brachytherapy is used extensively worldwide; it has been used in 800 medical centers in the United States and Western Europe for over 14 years.
This project will establish domestic production of microsources, titanium capsules containing a gold wire (
Microsources produced by the project will be used to treat prostate, liver, and pancreatic cancers. Prostate cancer is one of the most common diseases in the country. There are more than 2.5 million cancer patients in Russia for whom effective treatment is essential. The project has high social significance.
Area of application
- Medicine
Market
- Medical facilities and physicians treating patients with prostate cancer
Competitive advantages
- Products without Russian analogue
- Competitive price
- Minimal side effects
- Shorter hospital stays
News
-
26 June 2014
Technologies and Products
Titanium capsules containing a gold wire (x-ray marker) and radionuclide 125I (iodine-125) in the form of silver iodide whose surface has been modified for better ultrasound visualization.